← Back to Search

Optical Lens

Treatment 1 - Diffusion Optics Technology (DOT) Pattern for Near-sightedness (ASH-2 Trial)

N/A

Waitlist Available

Research Sponsored by SightGlass Vision, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Are 8-14 years of age;

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 minutes and 60 minutes

Awards & highlights

ASH-2 Trial Summary

This trial will test new lenses to see if they improve vision health.

Who is the study for?

This trial is for children aged 8-14 who can read or understand an assent document, have a parent or guardian to sign permission, and have near-sightedness within specific limits (+1.00D to -1.00D). They must be able to follow instructions.Check my eligibility

What is being tested?

The study tests if DOT spectacle lenses affect the thickness and vascularity of the choroid (a part of the eye) compared to standard control lenses in children with near-sightedness.See study design

What are the potential side effects?

Since this trial involves wearing special spectacle lenses, side effects may include discomfort while adjusting to new lenses, potential headaches or eye strain.

ASH-2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 8 and 14 years old.

ASH-2 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 minutes and 60 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 minutes and 60 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes and 60 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Choroiditis

Retinal and Choroidal Thickness

Secondary outcome measures

Software Method Comparison

ASH-2 Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Treatment 1 - Diffusion Optics Technology (DOT) PatternExperimental Treatment1 Intervention

Group II: Treatment 2 - Control SpectaclesActive Control1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

SightGlass Vision, Inc.Lead Sponsor

10 Previous Clinical Trials

1,063 Total Patients Enrolled

University of WaterlooOTHER

124 Previous Clinical Trials

209,328 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are persons younger than 65 years of age admissible to this clinical trial?

"This clinical trial is specially designed for individuals aged 8 to 14. For those under 18, there are 64 separate trials available and 16 studies have been created specifically targeting people over 65 years old."

Answered by AI

Might I be qualified to participate in this experiment?

"This research endeavour is searching for 30 minors, aged 8-14 years old and who have myopia. In order to qualify, these patients must demonstrate the ability to read or understand spoken language; be accompanied by a parent/guardian at all times; present emmetropic vision when tested with autorefraction (+1.00D/-1.00D); abide by instructions given in this trial; and sign documentation attesting to their understanding of what they are participating in."

Answered by AI

Is this research endeavor now accepting participants?

"As per clinicaltrials.gov, this medical trial has closed its recruitment period. Originally posted on November 14th 2022, the project was updated two days later and is no longer registering participants. However, there are 99 other studies that remain open to enrollees at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness

2023. "Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05617794.

All > Myopia